Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 180

    1.

    Discontinuing anticytomegalovirus therapy in patients with cytomegalovirus retinitis and AIDS.

    Jabs DA.

    Br J Ophthalmol. 2001 Apr;85(4):381-2. No abstract available. PMID: 11264121 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Suspension of anticytomegalovirus maintenance therapy following immune recovery due to highly active antiretroviral therapy.

    Curi AL, Muralha A, Muralha L, Pavesio C.

    Br J Ophthalmol. 2001 Apr;85(4):471-3.PMID: 11264139 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Discontinuing anticytomegalovirus therapy in patients with immune reconstitution after combination antiretroviral therapy.

    Jabs DA, Bolton SG, Dunn JP, Palestine AG.

    Am J Ophthalmol. 1998 Dec;126(6):817-22.PMID: 9860006 [PubMed - indexed for MEDLINE]Related articles

    4.

    Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis.

    Margolis TP.

    Surv Ophthalmol. 2000 Mar-Apr;44(5):455. No abstract available. PMID: 10809654 [PubMed - indexed for MEDLINE]Related articles

    5.

    Immune-recovery uveitis in patients with cytomegalovirus retinitis taking highly active antiretroviral therapy.

    Robinson MR, Reed G, Csaky KG, Polis MA, Whitcup SM.

    Am J Ophthalmol. 2000 Jul;130(1):49-56.PMID: 11004259 [PubMed - indexed for MEDLINE]Related articles

    6.

    Cytomegalovirus retinitis in HIV-infected patients with and without highly active antiretroviral therapy.

    Doan S, Cochereau I, Guvenisik N, Diraison MC, Mousalatti H, Thanh HX.

    Am J Ophthalmol. 1999 Aug;128(2):250-1.PMID: 10458193 [PubMed - indexed for MEDLINE]Related articles

    7.

    Characteristics of patients with cytomegalovirus retinitis in the era of highly active antiretroviral therapy.

    Jabs DA, Van Natta ML, Kempen JH, Reed Pavan P, Lim JI, Murphy RL, Hubbard LD.

    Am J Ophthalmol. 2002 Jan;133(1):48-61.PMID: 11755839 [PubMed - indexed for MEDLINE]Related articles

    8.

    Immune recovery uveitis.

    Kuppermann BD, Holland GN.

    Am J Ophthalmol. 2000 Jul;130(1):103-6. Review. No abstract available. PMID: 11004267 [PubMed - indexed for MEDLINE]Related articles

    9.

    Five-year follow-up of a cohort of profoundly immunosuppressed patients discontinuing therapy for cytomegalovirus retinitis.

    Sklar PA, Agyemang AF, Monastra R, Kress DR, Metcalf JA, Robinson MR, Masur H, Polis MA.

    AIDS. 2004 Feb 20;18(3):567-9.PMID: 15090813 [PubMed - indexed for MEDLINE]Related articles

    10.

    Characteristics of untreated AIDS-related cytomegalovirus retinitis. II. Findings in the era of highly active antiretroviral therapy (1997 to 2000).

    Holland GN, Vaudaux JD, Shiramizu KM, Yu F, Goldenberg DT, Gupta A, Carlson M, Read RW, Novack RD, Kuppermann BD; Southern California HIV/Eye Consortium.

    Am J Ophthalmol. 2008 Jan;145(1):12-22.PMID: 18154751 [PubMed - indexed for MEDLINE]Related articles

    11.

    Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy.

    Uthayakumar S, Birthistle K, Dalton R, Hay PE.

    Lancet. 1997 Aug 23;350(9077):588-9; author reply 590. No abstract available. PMID: 9284793 [PubMed - indexed for MEDLINE]Related articles

    12.

    Immune recovery uveitis.

    Dunn JP.

    Hopkins HIV Rep. 2001 Nov;13(6):9-10. No abstract available. PMID: 11727417 [PubMed - indexed for MEDLINE]Related articles

    13.

    Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy in HIV infected patients: natural history and clinical predictors.

    Lin DY, Warren JF, Lazzeroni LC, Wolitz RA, Mansour SE.

    Retina. 2002 Jun;22(3):268-77.PMID: 12055458 [PubMed - indexed for MEDLINE]Related articles

    14.

    Discontinuation of maintenance therapy in patients with quiescent cytomegalovirus retinitis and elevated CD4+ counts.

    Vrabec TR, Baldassano VF, Whitcup SM.

    Ophthalmology. 1998 Jul;105(7):1259-64.PMID: 9663231 [PubMed - indexed for MEDLINE]Related articles

    15.

    Long-term follow-up of a cohort of HIV-infected patients who discontinued maintenance therapy for cytomegalovirus retinitis.

    Walmsley SL, Raboud J, Angel JB, Mazzulli T, Shen S, Casciaro L, Young CD, Moussa G, Gough K, Rachlis A, Hopkins J.

    HIV Clin Trials. 2006 Jan-Feb;7(1):1-9.PMID: 16632459 [PubMed - indexed for MEDLINE]Related articles

    16.

    Cytomegalovirus retinitis in the era of highly active antiretroviral therapy.

    Zegans M, Marsh B, Walton RC.

    Int Ophthalmol Clin. 2000 Spring;40(2):127-35. Review. No abstract available. PMID: 10791261 [PubMed - indexed for MEDLINE]Related articles

    17.

    Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: 1. Retinitis progression.

    Jabs DA, Van Natta ML, Thorne JE, Weinberg DV, Meredith TA, Kuppermann BD, Sepkowitz K, Li HK; Studies of Ocular Complications of AIDS Research Group.

    Ophthalmology. 2004 Dec;111(12):2224-31.PMID: 15582078 [PubMed - indexed for MEDLINE]Related articles

    18.

    Effect of anti-cytomegalovirus therapy on the incidence of immune recovery uveitis in AIDS patients with healed cytomegalovirus retinitis.

    Song MK, Azen SP, Buley A, Torriani F, Cheng L, Chaidhawangul S, Ozerdem U, Scholz B, Freeman WR.

    Am J Ophthalmol. 2003 Oct;136(4):696-702.PMID: 14516810 [PubMed - indexed for MEDLINE]Related articles

    19.

    Exploring the benefits and limits of highly active antiretroviral therapy.

    D'Aquila R, Walker B.

    JAMA. 1999 Nov 3;282(17):1668-9. No abstract available. PMID: 10553795 [PubMed - indexed for MEDLINE]Related articles

    20.

    Supplemental Content

    Find related data